Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Williamson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Transfusion|May 28, 2021
Minipool testing for SARS-CoV-2 RNA in United States blood donorsSonia Bakkour, Paula Saá, Jamel A Groves, et al.
Emerging Infectious Diseases|March 7, 2017
Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016Michelle S Chevalier, Brad J Biggerstaff, Sridhar V Basavaraju, et al.
Emerging Infectious Diseases|June 25, 2014
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United StatesPeter J Krause, Sukanya Narasimhan, Gary P Wormser, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Microbiology Spectrum|May 25, 2022
Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic StudiesMarcus P Wong, Michelle A Meas, Cameron Adams, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Transfusion|May 28, 2021
Minipool testing for SARS-CoV-2 RNA in United States blood donorsSonia Bakkour, Paula Saá, Jamel A Groves, et al.
Emerging Infectious Diseases|March 7, 2017
Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016Michelle S Chevalier, Brad J Biggerstaff, Sridhar V Basavaraju, et al.
Emerging Infectious Diseases|June 25, 2014
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United StatesPeter J Krause, Sukanya Narasimhan, Gary P Wormser, et al.
Transfusion|May 24, 2022
How do we…form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?Rebecca V Fink, Lois Fisher, Hasan Sulaeman, et al.
Microbiology Spectrum|May 25, 2022
Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic StudiesMarcus P Wong, Michelle A Meas, Cameron Adams, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 3